1. Home
  2. MYGN vs SSTK Comparison

MYGN vs SSTK Comparison

Compare MYGN & SSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.59

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$16.51

Market Cap

596.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
SSTK
Founded
1991
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
596.1M
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
MYGN
SSTK
Price
$4.59
$16.51
Analyst Decision
Buy
Buy
Analyst Count
8
2
Target Price
$7.64
$25.00
AVG Volume (30 Days)
1.7M
236.2K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
8.67%
EPS Growth
N/A
23.76
EPS
N/A
1.25
Revenue
$771,400,000.00
N/A
Revenue This Year
$6.89
$4.35
Revenue Next Year
$5.35
N/A
P/E Ratio
N/A
$13.29
Revenue Growth
2.33
N/A
52 Week Low
$3.76
$14.35
52 Week High
$8.63
$29.50

Technical Indicators

Market Signals
Indicator
MYGN
SSTK
Relative Strength Index (RSI) 46.49 48.07
Support Level $4.24 $15.75
Resistance Level $5.69 $17.81
Average True Range (ATR) 0.29 0.60
MACD -0.00 0.04
Stochastic Oscillator 48.83 43.85

Price Performance

Historical Comparison
MYGN
SSTK

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

Share on Social Networks: